Reps. Craig, McBath, Landsman, Horsford, Schrier Introduce Bill to Cap Price of Insulin at $35 Per Month
WASHINGTON, DC – Today, during Diabetes Awareness Month, U.S. Representatives Angie Craig (MN-02), Lucy McBath (GA-06), Greg Landsman (OH-01), Steven Horsford (NV-04) and Kim Schrier (WA-08) introduced the Affordable Insulin Now Act to help Americans with private insurance afford insulin.
The bill would extend the $35 insulin cap for seniors on Medicare that was passed into law through the Inflation Reduction Act (IRA) to all Americans with private insurance.
“For years, pharmaceutical companies have raked in record profits by price gouging consumers – forcing everyday Minnesotans to make the impossible choice between picking up lifesaving prescriptions and putting food on the table,” said Rep. Craig. “We have seen over time that the pressure we’ve put on Big Pharma is working, and this bill is the next step in our fight to make insulin affordable for every American who needs it.”
"No person should be forced to skip or ration medication because they cannot afford it," said Rep. McBath. "With health care affordability concerns more relevant than ever, we must work with urgency to address some of the most common medical expenses that strain American household budgets. I am grateful to my colleagues for our continued work to drive down the cost of insulin for all who need it."
“Insulin is a lifesaving medication, but every day in this country people are forced to make drastic financial decisions just to afford it,” said Rep. Landsman. “Americans deserve affordable healthcare, and we have to finish the job of capping insulin costs, so no one has to struggle to survive.”
“High insulin prices can cost someone their life,” said Rep. Horsford. “I’m proud to partner with Representatives Craig, Landsman, McBath, and Schrier to make sure this critical medication is accessible and affordable to all who need it. State lawmakers in Nevada passed a bill ensuring affordable insulin prices earlier this summer, and the bill we’re introducing today will expand that effort nationally. As tens of millions of Americans stand to lose health care coverage from Republican ‘Big Beautiful’ bill cuts and their refusal to extend health care tax credits, there has never been a more important time to pass the Affordable Insulin Now Act into law.”
"As a doctor and someone who has lived with type 1 diabetes for over four decades, I have seen how the price of insulin has skyrocketed over the years and know firsthand the pressure that these price hikes have put on patients," said Rep. Schrier, M.D. “Unaffordable insulin has even forced some to ration or go completely without the medication their lives depend on, with deadly consequences. I was proud to work with my colleagues to cap the cost of insulin for those on Medicare, and I am thrilled to continue our work to lower the price of this lifesaving medication for millions more."
The bill is also endorsed by Protect Our Care, the American Diabetes Association, Social Security Works and Breakthrough T1D.
“No one should go bankrupt buying the insulin that keeps them alive,” said Protect Our Care Director of Policy Programs Vaishu Jawahar. “By capping what privately insured Americans pay out-of-pocket for insulin, the Affordable Insulin Now Act extends a critical lifeline to diabetics and their families. While Donald Trump and Republicans in Congress continue driving up drug costs and padding drug company profits, this legislation will save lives and make health care more affordable for everyday Americans.”
“The ADA supports the Affordable Insulin Now Act, which would limit out-of-pocket cost for insulin at $35 a month for individuals with private health insurance,” said Catherine Ferguson, Vice President for Federal Advocacy, the American Diabetes Association. “This bill is a critical step to ensure people with diabetes who need insulin to live can afford it.”
"No one should suffer, go bankrupt, or die because big pharma billionaires are price gouging the insulin they need to survive,” said Alex Lawson, Executive Director, Social Security Works. “This bill is a critical step towards ensuring that insulin is affordable and protecting Americans from the criminally high prices that pharmaceutical companies charge."
Since entering Congress, Rep. Craig has been a leader in the fight to lower prescription drug prices with a specific focus on insulin. In 2022, the provision of Rep. Craig’s bill that capped insulin copays at $35/month for Medicare recipients was signed into law as part of the IRA.
Last Congress, Rep. Craig also introduced the Emergency Access to Insulin Act to help Americans without health insurance afford insulin. This bill would expand emergency insulin access, lower costs for those without health insurance and take additional steps to hold drug companies accountable for price gouging Americans.
During IRA negotiations, Rep. Craig stood with House progressives, refusing to support the bill until it included provisions to allow Medicare to negotiate drug prices. She is also cosponsor of the Lowering Drug Costs for American Families Act, which would expand Medicare drug price negotiation to lower the price of additional prescription drugs.
You can read the text of the bill here.
###